SCHEMBL7985325

SCHEMBL7985325

Cc1cc(C)cc(-c2nc(O)c3c(ncn3Cc3ccccc3)n2)c1

nearest known ligand 0.42

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HPGD P15428 1/20 0.42
SMN1; SMN2 Q16637 5/20 0.42
ALDH1A1 P00352 3/20 0.42
GAA P10253 2/20 0.41
CYP11B1 P15538 4/20 0.41
CYP11B2 P19099 4/20 0.41
KMT2A Q03164 1/20 0.39
ADORA2B P29275 1/20 0.38
RXFP1 Q9HBX9 1/20 0.38
NR1I2 O75469 1/20 0.38
LMNA P02545 2/20 0.38
ADORA2A P29274 1/20 0.37
PARN O95453 1/20 0.37
CNOT7 Q9UIV1 1/20 0.37
TNF P01375 1/20 0.37
PKM P14618 1/20 0.36
TSHR P16473 1/20 0.36
HTT P42858 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7988594 0.92 TP53 (0.44) HPGDSMN1; SMN2ALDH1A1GAACYP11B1
SCHEMBL7984888 0.91 HPGD (0.41) HPGDSMN1; SMN2ALDH1A1GAAKMT2A
SCHEMBL7988787 0.89 SMN1; SMN2 (0.42) HPGDSMN1; SMN2ALDH1A1GAACYP11B1
SCHEMBL7975267 0.89 SMN1; SMN2 (0.46) HPGDSMN1; SMN2ALDH1A1GAACYP11B1
SCHEMBL7984717 0.88 SMN1; SMN2 (0.46) HPGDSMN1; SMN2ALDH1A1GAACYP11B1
SCHEMBL7974268 0.87 CYP11B1 (0.48) HPGDSMN1; SMN2ALDH1A1GAACYP11B1
SCHEMBL7985348 0.86 GAA (0.53) HPGDSMN1; SMN2ALDH1A1GAACYP11B1
SCHEMBL8056959 0.86 NR1H4 (0.39) HPGDSMN1; SMN2ALDH1A1GAAKMT2A
SCHEMBL7986237 0.85 MAOB (0.41) HPGDSMN1; SMN2ALDH1A1GAAKMT2A
SCHEMBL7988558 0.85 SMN1; SMN2 (0.43) HPGDSMN1; SMN2ALDH1A1GAACYP11B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed